Drugs For Erectile Dysfunction Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

The Business Research Company’s Drugs For Erectile Dysfunction Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, March 16, 2022 /EINPresswire.com/ -- New drug delivery techniques such as the use of pellets and creams are being implemented by many companies shaping the drugs for erectile dysfunction market outlook. Pellets and creams will have more efficacy and performance in erectile dysfunction and these are also more effective and safer to use. These benefits from drug delivery techniques will increase the scope of erectile dysfunction drugs market.

The global drugs for erectile dysfunction market size is expected to grow from $3.09 billion in 2021 to $3.18 billion in 2022 at a compound annual growth rate (CAGR) of 2.8%. The growth in the market size is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The drugs for erectile dysfunction market share is expected to reach $3.36 billion in 2026 at a CAGR of 1.3%.

Read more on the Global Drugs For Erectile Dysfunction Market Report:
https://www.thebusinessresearchcompany.com/report/drugs-for-erectile-dysfunction-global-market-report

Drastic increase in the number of chronic diseases drives the erectile dysfunction drugs market. Erectile dysfunction is mainly caused by chronic diseases resulting from sedentary lifestyle such as cardiovascular diseases, diabetes, obesity, and high blood pressure. According to WHO, prevalence of chronic diseases is expected to grow by 57% by the end of year 2020. Prevalence of chronic diseases increases the chances of erectile dysfunction among men, thereby driving the erectile dysfunction drugs market.

Major players covered in the global drugs for erectile dysfunction industry are Eli Lilly and Co., Pfizer, Bayer AG, Dong-A Pharmaceutical Co. Ltd, Vivus, Meda Pharmaceuticals, Apricus Biosciences, Cristália, S.K. Chemicals Co and Teva Pharmaceutical Industries Ltd.

North America is the largest region in the erectile dysfunction (ED) drugs market in 2021. The Middle East is expected to be the fastest growing region in the ED drugs market during the forecast period. The regions covered in the erectile dysfunction drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

TBRC’s global drugs for erectile dysfunction market report is segmented by drug into sildenafil citrate, mirodenafil, vardenafil, by end-user into hospital pharmacies, retail pharmacies, online pharmacies, by mode of administration into oral, topical, injection.

Drugs For Erectile Dysfunction Global Market Report 2022 – By Drugs (Sildenafil Citrate, Mirodenafil , Vardenafil), By End Users (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Mode of Administration (Oral, Topical, Injections) – Market Size, Trends, And Global Forecast 2022-2026 is one of a series of new reports from The Business Research Company that provides a drugs for erectile dysfunction market overview, drugs for erectile dysfunction market forecast, drugs for erectile dysfunction market size and drugs for erectile dysfunction market growth for the whole market, drugs for erectile dysfunction market segments, drugs for erectile dysfunction market geographies, drugs for erectile dysfunction market trends, drugs for erectile dysfunction market drivers, drugs for erectile dysfunction market restraints, leading competitors’ revenues, profiles, and market shares.

Request for a Sample of the Global Drugs For Erectile Dysfunction Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2443&type=smp

Not what you were looking for? Here is a list of similar reports by The Business Research Company:
Drugs For Hormonal Replacement Therapy Global Market Report 2022 – By Therapy Type (Estrogen Replacement Therapy, Human Growth Hormone (HGH) Replacement Therapy, Thyroid Replacement Therapy, Testosterone Replacement Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Hypothyroidism, Male Hypogonadism, Growth Hormone Deficiency, Menopause), By Route of Administration (Oral, Parental) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/drugs-for-hormonal-replacement-therapy-global-market-report

Biosimilar Hormones Global Market Report 2022 – By Type (Teriparatide Biosimilars, Follitropin Alfa Biosimilars, Insulin Biosimilars, Somatropin Biosimilars), By Application (Research & Biotechnology, Diagnostics, Biocatalysts, Therapeutics), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/epharmacy, Specialty Clinics) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/biosimilar-hormone-global-market-report

Biosimilar Growth Hormones Global Market Report 2022 – By Route Of Administration (Intravenous, Subcutaneous, Intramuscular, Oral), By Application (Growth Hormone Deficiency, Turner Syndrome, Idiopathic Short Stature, Prader Willi Syndrome), By Distribution Channel (Hospital And Retail Pharmacy, Online Pharmacy/Epharmacy, Specialty Clinics) – Market Size, Trends, And Global Forecast 2022-2026
https://www.thebusinessresearchcompany.com/report/biosimilar-growth-hormone-global-market-report

About The Business Research Company?
The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
LinkedIn: https://bit.ly/3b7850r
Twitter: https://bit.ly/3b1rmjS
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.